About 200 reports

Biotechnology Products Industry Industry Forecasts - China Focus

180 pages • By Asia Market Information & Development Company

This study focuses on China’s Biotechnology Products industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers...

1636 1800 1391
May 2017

Bio Industry Markets in China

381 pages • By Asia Market Information & Development Company

China’s demand for Bio Industry has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and...

3636 4000 3091
May 2017

Biotechnology Products Companies in China

147 pages • By Asia Market Information & Development Company

This study focuses on China’s Biotechnology Products industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

1636 1800 1391
May 2017

Global Single-use Bioprocessing System Market 2017-2021

70 pages • By Infiniti Research Limited

About Single-Use Bioprocessing System The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of biopharmaceutical products. Bioprocess is a technique that produces biological materials such as a genetically engineered microbial...

3398 3500 2922
Apr 2017

The 2018-2023 World Outlook for Biopharmaceuticals

293 pages • By ICON Group

This study covers the world outlook for biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Biosimilar Drugs

293 pages • By ICON Group

This study covers the world outlook for biosimilar drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Biosimilars

292 pages • By ICON Group

This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Biosimilars and Related Biologics

294 pages • By ICON Group

This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Nucleic Acid Isolation and Purification

296 pages • By ICON Group

This study covers the world outlook for nucleic acid isolation and purification across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region,...

905 995 769
Apr 2017

Lyophilization Services for Biopharmaceuticals, 2017-2027

239 pages • By Roots Analysis Private Ltd.

INTRODUCTION The number of biopharmaceuticals being developed and manufactured has increased significantly in recent years. This is evident from the fact that over 10 novel biologics have been approved annually by FDA over the last three years; this represents around 30% of the total novel drugs approved during this time period....

2272 2499 1931
Apr 2017

Single-use Bioprocessing Systems Market - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

212 pages • By Transparency Market Research

Asia Pacific Single-use Bioprocessing System Market: Overview This report on single-use bioprocessing systems market studies the current as well as future prospects of the market in Asia Pacific. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various single-use...

5268 5795 4478
Apr 2017

Chorionic Gonadotrophin Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Chorionic Gonadotrophin Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Chorionic Gonadotrophin worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Chorionic Gonadotrophin by countries, and also find out...

1000 1100 850
Apr 2017

Somatropin Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Somatropin Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Somatropin worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Somatropin by countries, and also find out sales forecast until 2021. The research...

1000 1100 850
Apr 2017

Imiglucerase Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Imiglucerase Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Imiglucerase worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Imiglucerase by countries, and also find out sales forecast until 2021. The...

1000 1100 850
Apr 2017

Darbepoetin Alfa Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Darbepoetin Alfa Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Darbepoetin Alfa worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Darbepoetin Alfa by countries, and also find out sales forecast until...

1000 1100 850
Apr 2017

Human Menopausal Gonadotrophin Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Human Menopausal Gonadotrophin Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Human Menopausal Gonadotrophin worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Human Menopausal Gonadotrophin by countries,...

1000 1100 850
Apr 2017

Moroctocog Alfa Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Moroctocog Alfa Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Moroctocog Alfa worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Moroctocog Alfa by countries, and also find out sales forecast until 2021....

1000 1100 850
Apr 2017

Luteinising Hormone / Follicle-Stimulating Hormone Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Luteinising Hormone / Follicle-Stimulating Hormone Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Luteinising Hormone / Follicle-Stimulating Hormone worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of...

1000 1100 850
Apr 2017

Factor VIII Inhibitor Bypassing Fraction Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Factor VIII Inhibitor Bypassing Fraction Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor VIII Inhibitor Bypassing Fraction worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Factor VIII Inhibitor...

1000 1100 850
Apr 2017

Factor VIII / Von Willebrand factor Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Factor VIII / Von Willebrand factor Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor VIII / Von Willebrand factor worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Factor VIII / Von Willebrand factor...

1000 1100 850
Apr 2017

Tenecteplase Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Tenecteplase Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Tenecteplase worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Tenecteplase by countries, and also find out sales forecast until 2021. The...

1000 1100 850
Apr 2017

Alteplase Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Alteplase Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Alteplase worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Alteplase by countries, and also find out sales forecast until 2021. The research...

1000 1100 850
Apr 2017

Factor VIII Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Factor VIII Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor VIII worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Factor VIII by countries, and also find out sales forecast until 2021. The research...

1000 1100 850
Apr 2017

Factor IX Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Factor IX Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor IX worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Factor IX by countries, and also find out sales forecast until 2021. The research...

1000 1100 850
Apr 2017

Global Biopharmaceutical Market Report & Forecast (2017-2021)

207 pages • By International Market Analysis Research and Consult

The global biopharmaceutical Industry has come a long way since its first drug- Humulin was approved in 1982. Today hundreds of biopharmaceuticals have already been approved and many more are in late stages of clinical development. These drugs have not only advanced the prevention and treatment of a number of life threatening...

1817 1999 1545
Apr 2017

Global Biopharmaceutical Manufacturing Market Report 2017-2021

92 pages • By International Market Analysis Research and Consult

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2017-2021” provides a detailed analysis on the global biopharmaceutical manufacturing market. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compared to small molecules which are synthesized...

1817 1999 1545
Apr 2017

Global Personalized Medicine Partnering 2010 - 2017: Deal trends, players, financials and forecasts

1000 pages • By Currentpartnering

The Global Personalized Medicine Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies Description The Global Personalized Medicine Partnering 2010-2017 report provides...

3177 3495 2701
Apr 2017

Biosimilars: US Payer Perspectives

By Firstword Pharma

Biosimilars continue to be big business in the US, but has progress has been too slow? Not so, argue payers. While the number of biosimilar approvals in the US still lags behind Europe, a solid foundation continues to be laid by multiple key stakeholder groups. Successes have been seen in key areas, including the approval...

2225 2448 1647
Apr 2017

The Future of Biobetters

By Firstword Pharma

Description Strategies for success in the biobetter market How can you successfully position biobetter products in the increasingly crowded branded biologic/biosimilar space? With the prospect of improving patient adherence, meeting unmet clinical need and increasing revenues, investment in the biobetter...

2225 2448 1647
Apr 2017

Biosimilars Market, Europe, Forecast to 2025

133 pages • By Frost & Sullivan

A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive...

4500 4950 3825
Mar 2017